Table 1.

Clinical Data, Methods of Investigation Used, and Semiquantitative Scoring of Immunohistochemical Staining in the Series of 10 Patients

Samples Age/Sex Diagnosis Skin Lesion MethodCD30 (%) CD30L (%)
1  35/F* LyP Growing  IHC, MA, TCI  47  Neg  
2  76/M  LCL Growing  IHC, MA, TCI  83  Neg  
3  35/F* LyP Regressing  IHC, MA, TCI  22  19  
4  64/F  LCL Regressing  IHC, MA, TCI  41  44  
5  26/M  LCL Growing  IHC, MA, TCI  91  Neg  
6  55/M  LCL Regressing  IHC, MA, TCI  43  37  
7  47/M  LCL Regressing  IHC, TCI  49  40  
8  32/F  LyP Regressing  IHC, TCI  15  18  
9  49/F  LyP Regressing  IHP  30  52  
10  49/M  LyP Regressing  IHP  23  25  
11  40/F  LyP Regressing  IHP  19  20  
12  78/M  LCL Growing  IHC, TCI  80  Neg  
13  42/F  LyP Growing  IHC, TCI  41  Neg 
Samples Age/Sex Diagnosis Skin Lesion MethodCD30 (%) CD30L (%)
1  35/F* LyP Growing  IHC, MA, TCI  47  Neg  
2  76/M  LCL Growing  IHC, MA, TCI  83  Neg  
3  35/F* LyP Regressing  IHC, MA, TCI  22  19  
4  64/F  LCL Regressing  IHC, MA, TCI  41  44  
5  26/M  LCL Growing  IHC, MA, TCI  91  Neg  
6  55/M  LCL Regressing  IHC, MA, TCI  43  37  
7  47/M  LCL Regressing  IHC, TCI  49  40  
8  32/F  LyP Regressing  IHC, TCI  15  18  
9  49/F  LyP Regressing  IHP  30  52  
10  49/M  LyP Regressing  IHP  23  25  
11  40/F  LyP Regressing  IHP  19  20  
12  78/M  LCL Growing  IHC, TCI  80  Neg  
13  42/F  LyP Growing  IHC, TCI  41  Neg 

Abbreviations: LyP, lymphomatoid papulosis; LCL, large cell lymphoma; IHC, immunohistochemistry on cryostat sections; IHP, immunohistochemistry on paraffin sections; MA, molecular analysis (RT-PCR, Southern blot); TCI, two-color immunofluorescence; Neg, negative or <2%.

*

Samples 1 and 3 were taken from the same patient.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal